AYOXXA to develop multiplex immunoassay to support treatment of sepsis patients - NUS Enterprise

Skip to content

Start-Up Stories
News
Events
Funding
Contact Us

About Us
- About Us Menu
  About Us
  
  Our People
Education Programmes
Supporting Entrepreneurs
Partnering Corporates
- Partnering Corporates Template
  Corporate Partnerships
  Friends of NUS Enterprise
  Accelerators & Challenges
  
  PIER71
  
  ICE71
  
  InnovFest
Research and Resources
- Research and Resources Menu
  Research Projects
  Research Publications
  TechASEAN
  
  Newsletter
  Videos
  NUS Innovation and Venture Creation (IVC) Awards
Technology to Innovation
Quick Links
- Quick Links Template
  Start-Up Stories
  News
  Events
  Funding
  Contact Us

Homepage
News
AYOXXA to develop multiplex immunoassay to support treatment of sepsis patients

Homepage
News
AYOXXA to develop multiplex immunoassay to support treatment of sepsis patients

NUS Enterprise

21, Heng Mui Keng Terrace
Level 5
Singapore 119613
+65 6516 7175
enterprise@nus.edu.sg

© National University of Singapore. All Rights Reserved.

Legal
Branding guidelines
Contact Us